These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158 [TBL] [Abstract][Full Text] [Related]
4. Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management. Vendrell JA; Mau-Them FT; Béganton B; Godreuil S; Coopman P; Solassol J Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146051 [TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in breast cancer: applications in personalized medicine. Lee JS; Magbanua MJM; Park JW Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678 [TBL] [Abstract][Full Text] [Related]
6. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516 [TBL] [Abstract][Full Text] [Related]
7. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Alix-Panabières C; Pantel K Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689 [TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells in lung cancer. Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook. Tinhofer I; Staudte S Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647 [TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer. Maly V; Maly O; Kolostova K; Bobek V In Vivo; 2019; 33(4):1027-1037. PubMed ID: 31280190 [TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in breast cancer: A comprehensive review. Alimirzaie S; Bagherzadeh M; Akbari MR Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931 [TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806 [TBL] [Abstract][Full Text] [Related]
14. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer. Zhou J; Dong F; Cui F; Xu R; Tang X Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866 [TBL] [Abstract][Full Text] [Related]
15. Methods for detection of circulating cells in non-small cell lung cancer. Han Y; Su C; Liu Z Front Biosci (Landmark Ed); 2014 Jun; 19(6):896-903. PubMed ID: 24896324 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of circulating tumor cells-from bench to bedside. Li Y; Wu S; Bai F Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718 [TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer. Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642 [TBL] [Abstract][Full Text] [Related]
19. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring. Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656 [TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer. Ke H; Kao S; van Zandwijk N; Rasko JEJ; Yeo D Lung Cancer; 2024 Jun; 192():107829. PubMed ID: 38810528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]